Tag: Alexion Pharmaceuticals
Rubius reports $26.4M loss for Q3
PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...
Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield
SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...
Smart incentives help seal deal
Certainly it was good news when Rubius Therapeutics Inc. announced its intention to open a pharmaceutical manufacturing facility in Rhode Island.
It didn’t have to...
Alexion reports revenue up, profit down on restructuring costs
SMITHFIELD – New Haven, Conn.-based Alexion Pharmaceuticals Inc. reported a 17 percent year-over-year decline in net income for the 2017 third quarter to $78...
Government can help, but businesses control job growth
In her weekly video address heading into Labor Day weekend, Gov. Gina M. Raimondo touted the significant job gains in the state since she...
R.I. Alexion manufacturing facility to close in corporate restructuring
NEW HAVEN, Conn. – Alexion Pharmaceuticals Inc. will close its manufacturing facility in Smithfield, the company said Monday.
In a release announcing a restructuring in...
Alexion raided by Brazilian police in sales investigation
BRASILIA, Brazil - Alexion Pharmaceuticals Inc.’s Sao Paulo offices were raided by Brazilian authorities Monday as part of an investigation into the drugmaker’s sales...
- Featured Event -
